gastroparesis and glp 1 drugs GLP-1 Gastroparesis: What Patients Should Know? The GLP-1 Agonists and Obesity:

Originally designed to treat type 2 diabetes, these medications are now approved for weight management due to their impressive results in promoting healthy, sustainable weight loss

AstraZeneca PLC is a biopharmaceutical company that researches, develops, manufactures, and sells prescription drugs

In the STEP1 trial (100), Wilding et al

GLP-1RAs may improve endothelial cell function via anti-inflammatory and vasodilatory properties

Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM

Cell lines commonly used to study mechanisms of GLP-1 secretion are GLUTag, STC-1 and human colorectal adenocarcinoma-derived NCI-H716 cells